Clinical validation of a serum protein biomarker signature for the early diagnosis of pancreatic cancer.

Project Information

IMMPACT

Grant agreement ID: 672454

DOI 10.3030/672454

Project closed

EC signature date 15 July 2015

Start date 1 June 2015

End date 31 May 2018

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 4 244 969,25

EU contribution € 4 244 969,00

Coordinated by

IMMUNOVIA AB
Sweden

• Pancreatic cancer test to offer life-saving early diagnosis
  EN